LANDEC CORPORATION (NASDAQ:LNDC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

LANDEC CORPORATION (NASDAQ:LNDC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) (i)     On March 14, 2017, the authorized number of directors of the Board of Directors (the “Board”) of Landec Corporation (the “Company”) was increased from eight (8) to nine (9).

(ii)     On March 14, 2017, the Board elected Debbie Carosella to serve as a member of the Board as a Class 2 Director, and as a member of the Food Innovation Committee. Ms. Carosella has not had any direct or indirect material interest in any transaction since the beginning of the Company’s last fiscal year, or in any currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeds $120,000.


About LANDEC CORPORATION (NASDAQ:LNDC)

Landec Corporation designs, develops, manufactures and sells a range of health and wellness products for food and biomaterials markets. The Company licenses technology applications to partners. The Company operates through three segments: Packaged Fresh Vegetables, Food Export and Biomaterials. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. The Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products primarily to Asia. The Biomaterials segment sells products utilizing hyaluronan, a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-hyaluronan (HA) products for medical use primarily in the ophthalmic, orthopedic and other markets.

LANDEC CORPORATION (NASDAQ:LNDC) Recent Trading Information

LANDEC CORPORATION (NASDAQ:LNDC) closed its last trading session down -0.15 at 12.55 with 34,846 shares trading hands.